Drugs: Role in Human Health
DOI:
https://doi.org/10.70130/CAST.2022.5206Keywords:
ASPIRIN, DRUGS, MEDICINE, HEALTHCARE, COMPETITIVE INHIBITIONAbstract
Drugs are the chemical substances that may be natural or synthetic depending upon their origin. These are administered in the living body to cure certain types of ailments that happen. Drugs are substrate specific in their action and mode of administration decide active time required for action. There are many categories of drugs depending upon their mode of action and the type of disease that cures by these substances in living beings. These drugs inhibit the growth of microorganisms by following either a competitive or non-competitive mechanism. In the present chapter, different types of drugs are explained with their respective roles and categories.
References
Bhushan, A., & Vummenthala, A. (2021). Promising investigational therapeutic drugs for the treatment of COVID-19: A review.
Botting, R. (2004). Antipyretic therapy. Frontiers in Bioscience, 9(1-3), 956.
Church, M. K., & Church, D. S. (2013). Pharmacology of antihistamines. Indian Journal of Dermatology, 58(3), 219.
Dale, J. K., & Booth, R. E. (1955). A study of antacids. Journal of the American Pharmaceutical Association (Scientific ed.), 44(3), 170-177.
Di Lorenzo, G., Di Trolio, R., Kozlakidis, Z., Busto, G., Ingenito, C., Buonerba, L., & Leo, E. (2020). COVID 19 therapies and anticancer drugs: A systematic review of recent literature. Critical Reviews in Oncology/Hematology, 152, Article 102991. https://doi.org/10.1016/j.critrevonc.2020.102991
Ehrlich, P. (1911). Salvarsan treatment. The American Journal of the Medical Sciences, 141(5), 762.
Gao, Y., Shang, Q., Li, W., Guo, W., Stojadinovic, A., Mannion, C., & Chen, T. (2020). Antibiotics for cancer treatment: A double-edged sword. Journal of Cancer, 11(17), 5135-5149. https://doi.org/10.7150/jca.47470
Garg, V., Sharma, P., Chaudhary, N., Saini, S., Singh, P., Bhatt, S., & Bhatti, H. (2022). Antacids revisited: Review on contemporary facts and relevance for self-management. Journal of International Medical Research, 50(3), Article 030006052210864. https://doi.org/10.1177/03000605221086457
Grosset, J. H., & Singer, T. (2013). Streptomycin. In Brenner's encyclopedia of genetics (pp. 568-569).
Gupta, R. C., & Milatovic, D. (2011). Anticholinesterase pesticides interactions. In Anticholinesterase pesticides (pp. 315-327).
Habif, T. P., Campbell, J. L., Chapman, M. S., Dinulos, J. G. H., & Zug, K. A. (2011). Vesicular and bullous diseases. In Skin disease (pp. 366-377).
Hayes' handbook of pesticide toxicology. (2010). Academic Press.
Hernandez, C., Diaz-Heredia, J., Berraquero, M. L., Crespo, P., Loza, E., & Ruiz Iban, M. A. (2015). Pre-operative predictive factors of postoperative pain in patients with hip or knee arthroplasty: A systematic review. Reumatologia Clinica, 47(11), 361–380.
Hina, N., Fletcher, D., Poindessous-Jazat, F., & Martinez, V. (2015). Hyperalgesia induced by low-dose opioid treatment before orthopaedic surgery: An observational case-control study. European Journal of Anaesthesiology, 32, 255–261.
Kania, A., Skiba, G., Grabowiecka, A., Oleksyn, B. J., Tarasiuk, J., Puszynski, A., & Skupień, K. (2022). Preliminary studies of antimicrobial activity of new synthesized hybrids of 2-thiohydantoin and 2-quinolone derivatives activated with blue light. Molecules, 27(3), Article 1069.
Karim, S. M. (2012). Practical applications of prostaglandins and their synthesis inhibitors. Springer Science & Business Media.
Kawauchi, H., Yanai, K., Wang, D. Y., Itahashi, K., & Okubo, K. (2019). Antihistamines for allergic rhinitis treatment from the viewpoint of nonsedative properties. International Journal of Molecular Sciences, 20(1), Article 213.
Khan, M. A., Das, M. K., Hasan, M. S., Msyukur, M. K. B. M., & Hossain, M. S. (2022). Major drugs used in COVID-19 treatment: Molecular mechanisms, validation and current progress in trials. Coronaviruses, 3(2).
LaFleur, J. L., & Boddu, K. (2011). Monoamine oxidase inhibitors; Reversible inhibitors of monoamine oxidase. In Essence of anesthesia practice (p. 619).
Laux, G., & Dietmaier, O. (2006). Kombination von Psychopharmaka, Umstellungen. In Praktische Psychopharmakotherapie (pp. 134-142).
Lee, S.-H. (2014). Aspirin. In Encyclopedia of cancer (pp. 386-390).
Martinez, V., Beloeil, H., Marret, E., Fletcher, D., Ravaud, P., & Trinquart, L. (2017). Non-opioid analgesics in adults after major surgery. Survey of Anesthesiology, 61(3), 75.
McDonnell, G., & Russell, A. D. (1999). Antiseptics and disinfectants: Activity, action, and resistance. Clinical Microbiology Reviews, 12(1), 147-179.
Patil, E., & Edelman, A. (2015). Medical abortion: Use of mifepristone and misoprostol in first and second trimesters of pregnancy. Current Obstetrics and Gynecology Reports, 4(1), 69-78.
Pawson, P., & Forsyth, S. (2008). Anesthetic agents. In Small animal clinical pharmacology (pp. 83-112).
Pino, M. A., & Azer, S. A. (2022). Cimetidine. In StatPearls. StatPearls Publishing.
Rosen, M. A., & Hughes, S. C. (2005). Maternal and fetal anesthesia and analgesia. In Avery's diseases of the newborn (pp. 159-170).
Serés, E., & Bosch, F. (2010). Salvarsan: Early days of a new chemotherapeutic drug. Journal of Chemotherapy, 22(6), 433-433.
Terreni, M., Taccani, M., & Pregnolato, M. (2021). New antibiotics for multidrug-resistant bacterial strains: Latest research developments and future perspectives. Molecules, 26(9), Article 2671.
Tóth, L., Muszbek, L., & Komaromi, I. (2013). Mechanism of the irreversible inhibition of human cyclooxygenase-1 by aspirin as predicted by QM/MM calculations. Journal of Molecular Graphics and Modelling, 40, 99-109.
Whittaker, C. F., Miklich, M. A., Patel, R. S., & Fink, J. C. (2018). Medication safety principles and practice in CKD. Clinical Journal of the American Society of Nephrology, 13(11), 1738-1746.